Anthropic is entering one of the most closely watched stages ahead of its potential IPO.
The original author, Qinbafrank, highlighted a series of scenarios proposed by Gavin Baker, Managing Partner at Atreides Management. Baker speculated that Anthropic may be simultaneously adjusting its financial reporting framework, model release schedule, and growth narrative ahead of a potential public listing.
However, it is important to distinguish confirmed information from speculation.
Gavin Baker explicitly described his analysis as “Pure speculation.” What can be confirmed is that Anthropic has confidentially filed for an IPO, while the market expects the listing process to move forward in the fall of 2026. Reuters has also reported that the potential IPO launch could shift toward mid-October.
The more important question is therefore not whether Anthropic is “managing the narrative,” but:
How will public markets evaluate revenue quality, model competitiveness, and massive AI infrastructure spending once leading AI companies go public?
Why Might Anthropic Be Reframing Its ARR?
One of the most interesting parts of the original post concerns Anthropic’s revenue reporting.
According to Baker’s speculation, Anthropic may be moving from a more aggressive “Gross ARR” framework toward a more conservative “Net ARR” framework, while excluding some revenue streams that may be less stable.
This matters significantly before an IPO.
AI-company revenue is not always directly comparable with traditional SaaS revenue. Revenue can come from cloud distribution channels, token usage, enterprise contracts, and other partnerships, while companies may calculate ARR differently.
Axios recently noted that part of the apparent revenue gap between Anthropic and OpenAI may come from differences in how the two companies recognize and report revenue. Anthropic’s eventual public IPO filing could provide much clearer details.
Put simply:
Ahead of an IPO, investors will not only ask “How high is revenue?” They will increasingly ask “How real, stable, and sustainable is that revenue?”
This is one of the biggest changes AI companies face when moving from private-market valuations to public-market scrutiny.
Why Does Model Competition Matter for IPO Valuation?
The second major issue is model release timing.
According to qinbafrank’s summary of Baker’s view, the next several weeks could become another period of intensive AI model launches, with major laboratories competing for developers, enterprise customers, and consumers.
This matters because Anthropic’s valuation ultimately depends on more than revenue growth.
The chain looks more like:
Model capability → User growth → Enterprise adoption → Token usage → Revenue
If a competitor releases a significantly stronger model, customers may switch quickly.
Conversely, if Anthropic can demonstrate stronger models, accelerating ARR, and better enterprise retention before its IPO, the market may assign it a higher valuation.
AI model competition is therefore no longer just benchmark rankings.
A major model release is increasingly becoming a capital-market event.
Agents Could Become the Next Major Commercialization Layer
The original post also highlights another important trend:
AI Agents are moving beyond chat and toward actual execution.
Earlier AI products were mainly designed to answer questions.
The next stage increasingly focuses on:
Search → Analyze → Use tools → Execute tasks → Complete work
This is why enterprise-grade agents are becoming an important competitive area for AI companies.
If Agents can genuinely replace or automate parts of repetitive knowledge work, the AI business model could gradually evolve from simply selling tokens or subscriptions toward:
Selling models + Selling Agents + Selling productivity
That may ultimately matter more than simply comparing model benchmarks.
KTX View: Which Products Are Related to the Anthropic IPO Theme?
Anthropic has not yet completed its IPO, but the current AI model race is already affecting a much broader chain of technology assets.
For KTX users, there are three areas worth watching.
The first is AI model companies themselves.
KTX has launched the OPENAIUSDT pre-IPO perpetual contract. According to KTX’s official information, the product references market expectations related to OpenAI and does not represent direct ownership of officially listed OpenAI shares.
Progress toward an Anthropic IPO, together with competition between Anthropic and OpenAI, could influence valuation expectations across the broader AI-lab sector.
The second area is AI computing infrastructure.
The stronger AI models become and the more users they serve, the greater the demand for training and inference infrastructure.
KTX has also listed stock-themed perpetual contracts including ORCLUSDT, AMATUSDT, and CBRSUSDT. ORCL references Oracle, AMAT references Applied Materials, while CBRS is linked to market expectations around AI infrastructure company Cerebras.
The broader AI investment chain can therefore be summarized as:
Model upgrades → Higher Agent demand → Higher computing demand → Greater attention on data centers, chips, and semiconductor equipment
The third area is capital reallocation caused by the IPO itself.
If Anthropic enters public markets as a major technology IPO, investors may need to reallocate capital from other technology holdings to participate in the listing.
This means the Anthropic IPO could matter far beyond Anthropic itself.
It may become a broader repricing event for the AI sector.
KTX Market Outlook: What Should Investors Watch Next?
Three variables are especially important.
First, the actual financial data disclosed in Anthropic’s IPO filing.
Compared with market rumors, official disclosures on revenue, costs, customer concentration, and cash burn will be far more important.
Second, whether stronger models can actually generate more revenue.
Leading in model capability is one thing. Convincing enterprises to keep paying for those models is another.
Third, AI infrastructure spending continues to accelerate.
If AI demand continues expanding, companies involved in cloud infrastructure, semiconductor equipment, AI chips, and data centers may continue to benefit.
But if capital expenditure grows faster than AI commercialization, investors may begin questioning profitability.
So instead of only asking:
“Which company has the strongest model?”
A more important framework may be:
Model capability → Commercialization → Computing investment → Profitability
The key question is whether this entire chain can ultimately work.
Users who want to monitor AI, TradFi, and related technology assets can visit:
KTX stock-themed and pre-IPO perpetual products are derivatives. They do not represent direct ownership of the underlying companies or their equity and involve risks including leverage, funding fees, and liquidation.
FAQ
Has Anthropics already gone public?
No. Anthropic has confidentially filed for an IPO. Reuters has reported that the potential launch could move toward mid-October 2026, although the final schedule may still change.
Is Anthropic’s reported $65 billion ARR accurate?
There have been market reports around this figure, but AI companies may use different definitions for ARR, run rate, and channel revenue. Direct comparisons should therefore be made cautiously. Anthropic’s IPO filing should provide greater clarity.
Are Gavin Baker’s predictions official Anthropic information?
No. Baker explicitly described his comments as “Pure speculation.” His views on model release timing, customer revenue changes, and other details should be treated as personal analysis rather than confirmed Anthropic information.
Why could an Anthropic IPO affect AI stocks?
A major IPO could create a new valuation benchmark for the AI sector, attract capital away from other technology stocks, and influence investor expectations for AI-model companies, computing infrastructure, and semiconductor firms.
Can Anthropics be traded on KTX?
The KTX products discussed here primarily include OPENAIUSDT and AI-related stock-themed contracts such as ORCL, AMAT, and CBRS. Whether KTX launches an Anthropic-related product should be confirmed through the latest official KTX announcements and market pages.
Conclusion
The most important part of the Anthropic IPO story is not a particular model name or a single revenue rumor.
The bigger shift is that the AI industry is moving from asking:
“Who has the strongest model?”
toward:
“Who can turn model capability into sustainable revenue?”
Once Anthropic enters public markets, investors will likely scrutinize its revenue quality, customer structure, computing costs, and path to profitability far more closely.
At the same time, competition across new models, agents, and AI infrastructure continues to accelerate.
For KTX users, this broader theme can be viewed as:
AI Models → Agents → Computing Power → Semiconductors → Technology Asset Valuations
rather than focusing only on the short-term market reaction to a single model release.
Original Post
Gavin Baker, Managing Partner at Atreides, recently published an interesting speculative thread about what Anthropic might be doing ahead of its IPO in terms of “narrative and financial timing management.”
His interpretation of Anthropic’s recent moves:
1. De-risking the financial reporting framework first
He believes Anthropic may be shifting ARR from a gross-revenue basis to a net-ARR basis, while excluding certain portions from the reported $65 billion ARR:
Meta-related revenue, reportedly worth more than $5 billion, as well as revenue associated with Chinese distillation activity.
The reasoning would be straightforward:
- The market already expects Meta-related cooperation to potentially end after the IPO. Excluding that revenue beforehand would reduce the risk of an obvious post-IPO decline.
- It might also reduce the probability of Meta actually ending the relationship, depending on how the counterparty interprets the situation.
2. The model release strategy looks like “letting competitors play their cards first”
- Anthropic released Fable 5.1 first, potentially making OpenAI more comfortable releasing Astra. Gavin had a very positive impression of Astra and even believed it may be stronger than Anthropic expected.
- There are rumors that Anthropic has solved Navier–Stokes. If true, that would be extremely significant.
- Gavin expects Anthropic could release Fable 5.2 before the IPO, theoretically stronger than Astra. At the same time, September could show another clear acceleration in ARR, potentially accompanied by deliberate media leaks.
3. The next six weeks could be extremely crowded
Gavin expects the next six weeks may bring a dense wave of new model releases:
Grok 4.7, Meta’s Watermelon, ChatGPT 6.1, Gemini 4, and others.
He believes major AI labs are more confident in their roadmaps than they have been at almost any point in the past 18 months.
But “the opponent also gets a vote,” meaning plans may not unfold exactly as expected.
4. Agent products are starting to diverge
- Grok Bot: Gavin considers it the best enterprise-grade agentic harness currently available, and says it has fundamentally changed some of his own workflows.
- Instinct: A consumer-focused agentic harness that appears promising.
- Competing products are likely to release similar variants soon.
Meanwhile, overall AI demand continues to accelerate.
His summary: “Wild times.”
The CFO could be a hidden variable
He believes Krishna may be a very strong CFO.
Overall, Gavin Baker believes Anthropic may be doing three things ahead of its IPO:
Cleaning up the revenue framework, positioning model releases ahead of competitors, and preparing the September growth narrative.
At the same time, the entire AI industry appears to be entering another intensive model-release cycle.
Original Author: qinbafrank
X Account: @qinbafrank
Original Post: https://x.com/qinbafrank/status/2096428499888472142
AI companies, pre-IPO assets, stock-themed perpetual contracts, and technology-sector assets may experience significant volatility. Market rumors, model release schedules, and IPO valuations may change. This content is for informational and educational purposes only and does not constitute financial or investment advice.